Jason Christiansen speaks about Targeting extrachromosomal DNA (ecDNA), a new approach to treating cancers with high copy number gene amplification at the 5th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference
Jason Christiansen, Chief Technology Officer for Boundless Bio has served in multiple leadership positions overseeing the development of new technologies and strategies for, research, diagnostic use, and targeted therapy development. He has served as Head of Assay Development at Roche Sequencing Solutions, providing leadership in initiatives around oncology testing, Dx development, NIPT testing and platform […]